结果页面 2，板块：医疗保健，行业：药品制造商 – 仿制药，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
医疗保健 (279)
- {{item.name}}
- 所有版块
- 医疗保健 (279)
药品制造商 – 仿制药 (279)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Johnson & Johnson JNJ.BA | $11,450 13.53 USD |
-3.17
|
$418.82T 495.06B USD | $14.81K 17.51 USD | $11,350 13.42 USD | $11,625 13.74 USD | $418.82T 495.06B USD | 5.63 | $2.03K 2.4 USD | |
| AbbVie Inc. ABBV.BA | $21,775 25.74 USD |
-0.91
|
$379.14T 448.16B USD | $845 1 USD | $21,500 25.41 USD | $21,875 25.86 USD | $379.14T 448.16B USD | 8.23 | $2.65K 3.13 USD | |
| Johnson & Johnson JNJ.MX | $2,894.03 171.36 USD |
-4.61
|
$7.21T 427.07B USD | $355 21.02 USD | $2,883 170.71 USD | $2,950 174.68 USD | $7.21T 427.07B USD | 16.39 | $176.54 10.45 USD | |
| Johnson & Johnson JNJB34.SA | $55.6 11.27 USD |
-4.39
|
$2.1T 424.8B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.1T 424.8B USD | 16.35 | $3.4 0.69 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV.MX | $3,661.21 216.79 USD |
-2.39
|
$6.53T 386.62B USD | $565 33.45 USD | $3,656.67 216.52 USD | $3,694 218.73 USD | $6.53T 386.62B USD | 79.99 | $45.77 2.71 USD | |
| AbbVie Inc. ABBV34.SA | $65.59 13.29 USD |
-3.23
|
$1.9T 384.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.9T 384.56B USD | 79.02 | $0.83 0.17 USD | |
| Johnson & Johnson JNJ.VI | $132.52 144.86 USD |
-0.69
|
$319.66B 349.43B USD | $87 95.1 USD | $132.52 144.86 USD | $133.14 145.54 USD | $319.66B 349.43B USD | 16.54 | $8.01 8.76 USD | |
| Johnson & Johnson JNJ.F | $132.12 144.43 USD |
-1.3
|
$317.89B 347.5B USD | $157 171.62 USD | $132.12 144.43 USD | $133.52 145.96 USD | $317.89B 347.5B USD | 16.31 | $8.1 8.85 USD | |
| AbbVie Inc. 4AB.F | $168.8 184.52 USD |
-0.24
|
$298.58B 326.38B USD | $21 22.96 USD | $167.8 183.43 USD | $168.8 184.52 USD | $298.58B 326.38B USD | 80.00 | $2.11 2.31 USD | |
| AbbVie Inc. ABBV.VI | $168 183.65 USD |
-0.24
|
$298.57B 326.38B USD | $0 0 USD | $168 183.65 USD | $168.6 184.3 USD | $298.57B 326.38B USD | 80.38 | $2.09 2.28 USD | |
| AbbVie Inc. 4AB.DE | $165.4 180.8 USD |
-1.66
|
$294.3B 321.71B USD | $27 29.51 USD | $165.4 180.8 USD | $167.8 183.43 USD | $294.3B 321.71B USD | 78.76 | $2.1 2.3 USD | |
| Roche Holding AG ROGN.MX | $6,004.02 355.51 USD |
-9.94
|
$4.9T 289.93B USD | $221 13.09 USD | $6,004.02 355.51 USD | $6,004.02 355.51 USD | $4.9T 289.93B USD | 25.06 | $239.56 14.18 USD | |
| Novartis AG NVS.BA | $30,900 36.52 USD |
-2.29
|
$245.2T 289.83B USD | $41 0.05 USD | $30,775 36.38 USD | $31,025 36.67 USD | $245.2T 289.83B USD | 2.14 | $14.42K 17.05 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| AstraZeneca PLC AZN.BA | $39,300 46.45 USD |
-1.07
|
$238.93T 282.42B USD | $275 0.33 USD | $38,725 45.77 USD | $39,500 46.69 USD | $238.93T 282.42B USD | 6.99 | $5.62K 6.64 USD | |
| Merck & Co., Inc. MRK.BA | $17,775 21.01 USD |
-4.31
|
$228.07T 269.59B USD | $9.27K 10.96 USD | $17,725 20.95 USD | $18,025 21.31 USD | $228.07T 269.59B USD | 0.22 | $77.78K 91.94 USD | |
| Novartis AG NVSN.MX | $2,092.19 123.88 USD |
0
|
$4.22T 250.03B USD | $299 17.7 USD | $0 0 USD | $0 0 USD | $4.22T 250.03B USD | 16.72 | $125.11 7.41 USD | |
| Novartis AG N1VS34.SA | $61.69 12.5 USD |
0
|
$1.23T 248.7B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.23T 248.7B USD | 17.04 | $3.62 0.73 USD | |
| Roche Holding AG RHHBF | $328 — |
0
|
$245.59B — | $37 — | $325.88 — | $328 — | $245.59B — | 26.51 | $12.37 — | |
| AstraZeneca PLC AZNN.MX | $1,330 78.75 USD |
0
|
$4.12T 244.16B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.12T 244.16B USD | 27.24 | $48.81 2.89 USD | |
| AstraZeneca PLC A1ZN34.SA | $63.48 12.87 USD |
-2.58
|
$1.2T 242.34B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.2T 242.34B USD | 27.01 | $2.35 0.48 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Roche Holding AG RHO6.F | $34.11 37.28 USD |
-2.99
|
$214.72B 234.72B USD | $2.69K 2.94K USD | $34.11 37.28 USD | $34.11 37.28 USD | $214.72B 234.72B USD | 24.89 | $1.37 1.5 USD | |
| Merck & Co., Inc. MRK.MX | $1,495 88.52 USD |
-5.24
|
$3.93T 232.57B USD | $319 18.89 USD | $1,495 88.52 USD | $1,546.01 91.54 USD | $3.93T 232.57B USD | 11.07 | $135 7.99 USD | |
| Merck & Co., Inc. MRCK34.SA | $55 11.15 USD |
-3.81
|
$1.14T 231.33B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.14T 231.33B USD | 11.27 | $4.88 0.99 USD | |
| AstraZeneca PLC AZNCF | $135.36 — |
0
|
$211.58B — | $8 — | $127.45 — | $127.45 — | $211.58B — | 27.23 | $4.97 — | |
| Merck & Co., Inc. MRK.SN | $78.71 — |
+2.67
|
$207.36B — | $0 — | $0 — | $0 — | $207.36B — | 11.44 | $6.88 — | |
| AstraZeneca PLC ZEG.F | $121.25 132.54 USD |
-1.1
|
$187.96B 205.47B USD | $135 147.57 USD | $121.2 132.49 USD | $121.25 132.54 USD | $187.96B 205.47B USD | 27.12 | $4.47 4.89 USD | |
| AstraZeneca PLC ZEGA.F | $60.5 66.13 USD |
-0.82
|
$187.57B 205.04B USD | $5 5.47 USD | $60.5 66.13 USD | $60.5 66.13 USD | $187.57B 205.04B USD | 27.00 | $2.24 2.45 USD | |
| Novartis AG NOTA.F | $93.6 102.32 USD |
-3.51
|
$184.87B 202.09B USD | $9 9.84 USD | $93.6 102.32 USD | $93.6 102.32 USD | $184.87B 202.09B USD | 16.27 | $5.75 6.29 USD | |
| Amgen Inc. AMGN.BA | $10,425 12.32 USD |
-1.88
|
$166.84T 197.21B USD | $822 0.97 USD | $10,375 12.26 USD | $10,525 12.44 USD | $166.84T 197.21B USD | 0.16 | $62.01K 73.3 USD | |
| Merck & Co., Inc. 6MK.F | $68.5 74.88 USD |
-0.58
|
$172.41B 188.47B USD | $1.23K 1.34K USD | $68.4 74.77 USD | $68.8 75.21 USD | $172.41B 188.47B USD | 11.04 | $6.2 6.78 USD | |
| Merck & Co., Inc. MRK.VI | $68.2 74.55 USD |
-1.59
|
$171.25B 187.2B USD | $120 131.18 USD | $68.2 74.55 USD | $69 75.43 USD | $171.25B 187.2B USD | 11.12 | $6.13 6.7 USD | |
| Pfizer Inc. PFE.BA | $6,640 7.85 USD |
-0.45
|
$148.25T 175.23B USD | $11.87K 14.03 USD | $6,520 7.71 USD | $6,660 7.87 USD | $148.25T 175.23B USD | 2.12 | $3.12K 3.69 USD | |
| Amgen Inc. AMGN.MX | $5,453.8 322.93 USD |
0
|
$2.93T 173.64B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.93T 173.64B USD | 25.31 | $215.43 12.76 USD | |
| Gilead Sciences, Inc. GILD.BA | $29,425 34.78 USD |
-1.92
|
$145.97T 172.54B USD | $288 0.34 USD | $29,275 34.6 USD | $29,525 34.9 USD | $145.97T 172.54B USD | 5.46 | $5.38K 6.36 USD | |
| Amgen Inc. AMGN34.SA | $54.44 11.03 USD |
+0.72
|
$834.91B 169.22B USD | $0 0 USD | $0 0 USD | $0 0 USD | $834.91B 169.22B USD | 24.52 | $2.22 0.45 USD | |
| Pfizer Inc. PFE.MX | $444.1 26.3 USD |
-1.56
|
$2.55T 151.17B USD | $12.65K 749.03 USD | $439.56 26.03 USD | $450 26.65 USD | $2.55T 151.17B USD | 16.39 | $27.09 1.6 USD | |
| Pfizer Inc. PFIZ34.SA | $32.16 6.52 USD |
-1.38
|
$741.86B 150.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $741.86B 150.36B USD | 16.40 | $1.96 0.4 USD | |
| Gilead Sciences, Inc. GILD.MX | $1,910.62 113.13 USD |
0
|
$2.51T 148.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.51T 148.84B USD | 20.44 | $93.43 5.53 USD | |
| Gilead Sciences, Inc. GILD34.SA | $273.51 55.44 USD |
0
|
$730.45B 148.05B USD | $0 0 USD | $0 0 USD | $0 0 USD | $730.45B 148.05B USD | 20.24 | $13.51 2.74 USD | |
| Amgen Inc. AMGN.VI | $241.8 264.32 USD |
-0.19
|
$130.82B 143B USD | $0 0 USD | $241.15 263.61 USD | $241.8 264.32 USD | $130.82B 143B USD | 24.77 | $9.76 10.67 USD | |
| Amgen Inc. AMG.DE | $240.45 262.84 USD |
-0.74
|
$130.09B 142.2B USD | $26 28.42 USD | $240.45 262.84 USD | $241.45 263.94 USD | $130.09B 142.2B USD | 24.33 | $9.88 10.8 USD | |
| Amgen Inc. AMG.F | $239.05 261.31 USD |
-3.08
|
$128.54B 140.51B USD | $179 195.67 USD | $239.05 261.31 USD | $243.1 265.74 USD | $128.54B 140.51B USD | 24.17 | $9.89 10.81 USD | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$138.52B — | $0 — | $95.78 — | $95.78 — | $138.52B — | 20.12 | $4.76 — | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Bristol-Myers Squibb Company BMY.BA | $18,025 21.31 USD |
-3.09
|
$110.73T 130.88B USD | $736 0.87 USD | $17,975 21.25 USD | $18,250 21.57 USD | $110.73T 130.88B USD | 5.94 | $3.03K 3.58 USD | |
| Pfizer Inc. PFE.SN | $22.89 — |
-12.16
|
$130.14B — | $0 — | $0 — | $0 — | $130.14B — | 16.58 | $1.38 — | |
| Pfizer Inc. PFE.VI | $20.37 22.27 USD |
-0.2
|
$116.95B 127.84B USD | $50 54.66 USD | $20.33 22.22 USD | $20.45 22.35 USD | $116.95B 127.84B USD | 16.56 | $1.23 1.34 USD | |
| Gilead Sciences, Inc. GIS.F | $90.55 98.98 USD |
-0.2
|
$113.58B 124.16B USD | $1.22K 1.33K USD | $90.55 98.98 USD | $90.55 98.98 USD | $113.58B 124.16B USD | 21.10 | $4.29 4.69 USD | |
| Gilead Sciences, Inc. GIS.DE | $90.28 98.69 USD |
-0.93
|
$112.75B 123.25B USD | $49 53.56 USD | $90.1 98.49 USD | $91.41 99.92 USD | $112.75B 123.25B USD | 21.04 | $4.29 4.69 USD | |
| Gilead Sciences, Inc. GILD.VI | $90.14 98.54 USD |
-1.11
|
$112.55B 123.03B USD | $0 0 USD | $90.14 98.54 USD | $90.74 99.19 USD | $112.55B 123.03B USD | 21.25 | $4.24 4.63 USD | |
| Pfizer Inc. PFEB.F | $6.5 7.11 USD |
-0.76
|
$112.03B 122.46B USD | $5 5.47 USD | $6.5 7.11 USD | $6.5 7.11 USD | $112.03B 122.46B USD | 15.47 | $0.42 0.46 USD | |
| Sanofi SNW2.F | $44.8 48.97 USD |
-0.44
|
$110.94B 121.27B USD | $50 54.66 USD | $44.4 48.54 USD | $44.8 48.97 USD | $110.94B 121.27B USD | 17.99 | $2.49 2.72 USD | |
| Sanofi SNW.F | $89.49 97.82 USD |
-0.68
|
$110.68B 120.99B USD | $81 88.54 USD | $89.49 97.82 USD | $89.88 98.25 USD | $110.68B 120.99B USD | 17.93 | $4.99 5.45 USD | |
| Sanofi SANO.VI | $89.13 97.43 USD |
-1.71
|
$109.53B 119.73B USD | $0 0 USD | $89.13 97.43 USD | $89.85 98.22 USD | $109.53B 119.73B USD | 17.86 | $4.99 5.45 USD | |
| Bristol-Myers Squibb Company BMY.MX | $931.83 55.18 USD |
0
|
$1.91T 112.91B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.91T 112.91B USD | 17.72 | $52.56 3.11 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $261.48 53 USD |
-4.67
|
$554.1B 112.31B USD | $0 0 USD | $0 0 USD | $0 0 USD | $554.1B 112.31B USD | 17.21 | $15.19 3.08 USD | |
| GSK plc GSK.BA | $10,525 12.44 USD |
-2.09
|
$85.52T 101.09B USD | $630 0.74 USD | $10,400 12.29 USD | $10,550 12.47 USD | $85.52T 101.09B USD | 18.55 | $567.3 0.67 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| Bristol-Myers Squibb Company BRM.DE | $42.06 45.97 USD |
0
|
$85.59B 93.56B USD | $1.47K 1.61K USD | $41.9 45.8 USD | $43.22 47.24 USD | $85.59B 93.56B USD | 17.45 | $2.41 2.63 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $41.83 45.73 USD |
-0.4
|
$85.13B 93.06B USD | $0 0 USD | $41.82 45.71 USD | $41.83 45.73 USD | $85.13B 93.06B USD | 17.50 | $2.39 2.61 USD | |
| Bristol-Myers Squibb Company BRM.F | $41.65 45.52 USD |
-1.06
|
$84.75B 92.64B USD | $600 655.88 USD | $41.2 45.04 USD | $41.65 45.52 USD | $84.75B 92.64B USD | 17.20 | $2.42 2.65 USD | |
| Chugai Pharmaceutical CHGCF | $55.08 — |
0
|
$90.64B — | $400 — | $52.81 — | $55.08 — | $90.64B — | 32.21 | $1.71 — | |
| GSK plc GSKN.MX | $711 42.1 USD |
+3.18
|
$1.47T 87.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.47T 87.14B USD | 18.06 | $39.35 2.33 USD | |
| GSK plc G1SK34.SA | $40.72 8.25 USD |
-3.51
|
$426.93B 86.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $426.93B 86.53B USD | 18.42 | $2.21 0.45 USD | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $44.79 48.96 USD |
-0.84
|
$74.46B 81.4B USD | $29 31.7 USD | $44.79 48.96 USD | $44.9 49.08 USD | $74.46B 81.4B USD | 29.66 | $1.51 1.65 USD | |
| GSK GLAXF | $18 — |
0
|
$75.55B — | $1K — | $18.95 — | $18.95 — | $75.55B — | 17.82 | $1.01 — | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $20.34 22.23 USD |
-3.69
|
$38.34B 41.91B USD | $640 699.61 USD | $20.34 22.23 USD | $20.34 22.23 USD | $38.34B 41.91B USD | 21.41 | $0.95 1.04 USD | |
| Bayer Aktiengesellschaft BAYZF | $27.97 — |
+0.61
|
$27.48B — | $25 — | $27.8 — | $27.92 — | $27.48B — | 0 | -$2.92 — | |
| Bayer Aktiengesellschaft BAYER.BD | $9,680 26.77 USD |
-4.74
|
$9.51T 26.3B USD | $175 0.48 USD | $9,600 26.55 USD | $9,780 27.05 USD | $9.51T 26.3B USD | 0 | -$1,050.7 -2.9 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $23.96 26.19 USD |
-4.37
|
$23.54B 25.73B USD | $910 994.75 USD | $23.96 26.19 USD | $24.36 26.62 USD | $23.54B 25.73B USD | 0 | -$2.6 -2.8 USD | |
| Bayer Aktiengesellschaft BAYA.F | $5.95 6.5 USD |
-6.3
|
$23.38B 25.56B USD | $4.15K 4.54K USD | $5.95 6.5 USD | $5.95 6.5 USD | $23.38B 25.56B USD | 0 | -$0.65 -0.7 USD | |
| Biogen Inc. BIIB.MX | $2,854 168.99 USD |
0
|
$418.19B 24.76B USD | $0 0 USD | $2,854 168.99 USD | $2,854 168.99 USD | $418.19B 24.76B USD | 14.36 | $198.64 11.76 USD | |
| Biogen Inc. BIIB.BA | $11,000 13 USD |
0
|
$20.58T 24.33B USD | $233 0.28 USD | $10,800 12.77 USD | $11,000 13 USD | $20.58T 24.33B USD | 0.96 | $11.44K 13.52 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $40.2 43.94 USD |
-2.9
|
$21.33B 23.32B USD | $180 196.76 USD | $40.2 43.94 USD | $40.2 43.94 USD | $21.33B 23.32B USD | 10.17 | $3.95 4.32 USD | |
| Biogen Inc. BIIB34.SA | $117.52 23.82 USD |
0
|
$103.73B 21.03B USD | $0 0 USD | $0 0 USD | $0 0 USD | $103.73B 21.03B USD | 12.33 | $9.53 1.93 USD | |
| Biogen Inc. IDP.DE | $110.2 120.46 USD |
+0.32
|
$16.32B 17.84B USD | $40 43.73 USD | $110.2 120.46 USD | $111.1 121.45 USD | $16.32B 17.84B USD | 12.08 | $9.12 9.97 USD | |
| Biogen Inc. BIIB.VI | $109.8 120.03 USD |
+0.18
|
$16.29B 17.81B USD | $2 2.19 USD | $109.8 120.03 USD | $111 121.34 USD | $16.29B 17.81B USD | 12.18 | $9.01 9.85 USD | |
| Biogen Inc. IDP.F | $109.55 119.75 USD |
-0.41
|
$16.2B 17.71B USD | $14 15.3 USD | $109.55 119.75 USD | $109.6 119.81 USD | $16.2B 17.71B USD | 12.01 | $9.12 9.97 USD | |
| Astellas Pharma ALPMF | $9.7 — |
0
|
$17.36B — | $200 — | $10.12 — | $10.12 — | $17.36B — | 51.05 | $0.19 — | |
| Astellas Pharma Inc. YPH.F | $8.07 8.82 USD |
-1.32
|
$14.73B 16.1B USD | $1.6K 1.75K USD | $8.07 8.82 USD | $8.07 8.82 USD | $14.73B 16.1B USD | 47.45 | $0.17 0.19 USD | |
| Astellas Pharma Inc. YPHA.F | $7.9 8.64 USD |
-1.86
|
$14.65B 16.01B USD | $700 765.19 USD | $7.9 8.64 USD | $7.9 8.64 USD | $14.65B 16.01B USD | 46.47 | $0.17 0.19 USD | |
| Cipla Limited CIPLA.BO | $1,490.4 18.03 USD |
-1.91
|
$1.2T 14.56B USD | $171.17K 2.07K USD | $1,474.1 17.83 USD | $1,505.3 18.21 USD | $1.2T 14.56B USD | 24.15 | $61.69 0.75 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $51.2 55.97 USD |
-2.1
|
$10.55B 11.53B USD | $60 65.59 USD | $51.2 55.97 USD | $52.2 57.06 USD | $10.55B 11.53B USD | 25.60 | $2 2.19 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $51 55.75 USD |
-2.76
|
$10.51B 11.48B USD | $0 0 USD | $51 55.75 USD | $51.9 56.73 USD | $10.51B 11.48B USD | 25.50 | $2 2.19 USD | |
| Orion Oyj ORINY | $29.1 — |
0
|
$8.64B — | $103 — | $32.45 — | $32.45 — | $8.64B — | 20.93 | $1.39 — | |
| Orion Oyj OFK0.F | $27.6 30.17 USD |
+1.47
|
$7.77B 8.5B USD | $0 0 USD | $27.6 30.17 USD | $27.6 30.17 USD | $7.77B 8.5B USD | 22.25 | $1.24 1.36 USD | |
| Orion Oyj OFK.F | $54.95 60.07 USD |
-0.54
|
$7.75B 8.47B USD | $100 109.31 USD | $54.95 60.07 USD | $55.25 60.4 USD | $7.75B 8.47B USD | 22.15 | $2.48 2.71 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.64 0.7 USD |
+1.67
|
$7.43B 8.12B USD | $9.6K 10.49K USD | $0.64 0.7 USD | $0.64 0.7 USD | $7.43B 8.12B USD | 12.87 | $0.05 0.05 USD | |
| CSPC Pharmaceutical CHJTF | $0.64 — |
0
|
$8.1B — | $20K — | $0.6199 — | $0.6199 — | $8.1B — | 12.79 | $0.05 — | |
| CSPC Pharmaceutical Group Limited CVGU.F | $2.44 2.67 USD |
+1.67
|
$7.31B 7.99B USD | $250 273.28 USD | $2.44 2.67 USD | $2.44 2.67 USD | $7.31B 7.99B USD | 13.55 | $0.18 0.2 USD | |
| Kyowa Kirin KYKOF | $15.23 — |
-3.3
|
$7.97B — | $209 — | $15.23 — | $15.23 — | $7.97B — | 22.73 | $0.67 — | |
| Abbott India Limited ABBOTINDIA.BO | $30,348.45 367.17 USD |
-0.25
|
$644.88B 7.8B USD | $193 2.33 USD | $30,235 365.79 USD | $30,595 370.15 USD | $644.88B 7.8B USD | 48.42 | $626.73 7.58 USD | |
| Abbott India Limited ABBOTINDIA.NS | $30,300 366.58 USD |
-0.3
|
$644.57B 7.8B USD | $4.25K 51.37 USD | $30,250 365.97 USD | $30,645 370.75 USD | $644.57B 7.8B USD | 48.16 | $629.07 7.61 USD | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
| Kyowa Kirin Co., Ltd. KY4.F | $13.1 14.32 USD |
-2.24
|
$6.9B 7.54B USD | $150 163.97 USD | $13.1 14.32 USD | $13.1 14.32 USD | $6.9B 7.54B USD | 22.20 | $0.59 0.64 USD | |
| Grifols, S.A. G0FB.F | $6.8 7.43 USD |
+3.03
|
$5.72B 6.25B USD | $310 338.87 USD | $6.8 7.43 USD | $6.8 7.43 USD | $5.72B 6.25B USD | 29.56 | $0.23 0.25 USD | |
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
||||||||||
- {{ link.label }} {{link}}